Advertisement
Investors who would like more information about attending the UBS GlobalLife Sciences Conference should contact their UBS sales representative.
About American Oriental Bioengineering, Inc.
Advertisement
American Oriental Bioengineering is a leading, fully integrated, plantbased pharmaceutical and plant based nutraceutical company dedicated toimproving health through the development, manufacture and commercialization ofmodernized plant based products in China.
Safe Harbor Statement
This news release contains forward-looking statements as defined by thePrivate Securities Litigation Reform Act of 1995. Forward-looking statementsinclude statements concerning plans, objectives, goals, strategies, futureevents or performance, and underlying assumptions and other statements thatare other than statements of historical facts. These statements are subject touncertainties and risks including, but not limited to, product and servicedemand and acceptance, changes in technology, economic conditions, the impactof competition and pricing, government regulation, and other risks containedin reports filed by the Company with the Securities and Exchange Commission.All such forward-looking statements, whether written or oral, and whether madeby or on behalf of the company, are expressly qualified by the cautionarystatements and any other cautionary statements which may accompany theforward-looking statements. In addition, the company disclaims any obligationto update any forward-looking statements to reflect events or circumstancesafter the date hereof.
SOURCE American Oriental Bioengineering, Inc.
